We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Vegetable-Based Enzyme Replaces Trypsin for Dissociation of Adherent Cell Cultures

By LabMedica International staff writers
Posted on 12 May 2010
Biotech researchers working with cell cultures will be interested in a new vegetable-based enzyme that was developed to replace trypsin for the dissociation of adherent cells without risk of contamination from either animal or human viruses or bacteria.

The vegetable enzyme is a component of the "SplitKits” cell dissociation system, which is now being manufactured and marketed by Sera Laboratories International Ltd. More...
(Haywards Heath, United Kingdom).

"SplitKits” are available in three different formats, each being optimized for use with specific cell types: SplitKit Strong, for strongly adherent and bioreactor-cultured cells; SplitKit Moderate for moderately adherent cells; and SplitKit Mild for mildly adherent cells. Each format may be used with both serum-based and serum-free cultures. SplitKits may be stored under refrigeration and used at room temperature.

Studies conducted by independent research and biopharmaceutical laboratories have shown that SplitKits induce dissociation faster than trypsin. Greater control of the dissociation process produces homogeneous cell suspensions with minimal batch-to-batch variation. The SplitKits vegetable-based enzyme produces higher cell yields and better cell growth recovery following detachment than trypsin does. In addition, surface epitopes and cell membranes remain unaltered and fully functional, so that the cells are better suited for all downstream research activities.

"Drawing on 30 years of experience in cell culture, we have developed SplitKits to offer a significantly improved alternative to trypsin for either serum-based or serum-free protocols,” said Jenny Murray, managing director of Sera Laboratories International Ltd. "For use in both laboratory cell culture and biopharmaceutical manufacturing, the increasing regulation of the use of animal-based components in the biopharmaceutical manufacturing environment means that SplitKits also offer the industry a potentially safer, more compliant system for cell culture.”

Related Links:

Sera Laboratories International Ltd.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.